According to Meridian Bioscience's latest financial reports the company has $0.36 B in net assets.
A companyโs net assets is the sum of its assets minus the sum of its liabilities.
Year | Net assets | Change |
---|---|---|
2022-09-30 | $0.36 B | 12.11% |
2021-09-30 | $0.32 B | 32.58% |
2020-09-30 | $0.24 B | 29.67% |
2019-09-30 | $0.19 B | 8.86% |
2018-09-30 | $0.17 B | 3.44% |
2017-09-30 | $0.16 B | 1.87% |
2016-09-30 | $0.16 B | 0.36% |
2015-09-30 | $0.16 B | 3.01% |
2014-09-30 | $0.16 B | 3.86% |
2013-09-30 | $0.15 B | 8.61% |
2012-09-30 | $0.14 B | 3.05% |
2011-09-30 | $0.13 B | 0.85% |
2010-09-30 | $0.13 B | -0.39% |
2009-09-30 | $0.13 B | 7.33% |
2008-09-30 | $0.12 B | 13.76% |
2007-09-30 | $0.11 B | 19.17% |
2006-09-30 | $94.77 M | 13.14% |
2005-09-30 | $83.76 M | 154.37% |
2004-09-30 | $32.93 M | 19.82% |
2003-09-30 | $27.48 M | 12.73% |
2002-09-30 | $24.38 M | 6.26% |
2001-09-30 | $22.94 M |
Company | Net assets | differencediff. | Country |
---|---|---|---|
![]() Thermo Fisher Scientific TMO | $45.46 B | 12,252.30% | ๐บ๐ธ USA |
![]() Becton Dickinson BDX | $25.79 B | 6,908.62% | ๐บ๐ธ USA |
![]() Hologic HOLX | $5.01 B | 1,263.06% | ๐บ๐ธ USA |
![]() QuidelOrtho QDEL | $4.96 B | 1,249.42% | ๐บ๐ธ USA |